|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
1.77/-0.63
|
企业价值
11.10M
|
资产负债 |
每股账面净值
1.12
|
现金流量 |
现金流量率
--
|
损益表 |
收益
28.83M
|
每股收益
2.75
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/05 09:29 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. |